Ita Lu - Profile and Investment Details

Investor Profile

Ita Lu is a Venture Capital, Private Equity Firm based in United States with a diverse investment portfolio that includes companies such as Frequency Therapeutics, AEye, Tripresso, Light Field Lab, China Investment Development Corporation, Pavilion Data Systems, Inc., DSP Concepts, Inc., Metanoia Communications, Unilab, Inc., Fractyl Laboratories, Tantti Laboratory Inc. (subsidiary of Repligen), ARRIS, EirGenix, Inc., Avesha, Viracta Therapeutics, Regenacy Pharmaceuticals, C4 Therapeutics, . Over time, Ita Lu has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Ita Lu is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wearables, Telecommunications, Wellness, Women Founded, Engineering, Automotive, Information Technology (IT), Cloud Computing, Internet of Things (IoT), Diabetes, Mobile, Broadcasting, Software, Manufacturing, Biotechnology, Drug Development, Podcasts, Productivity Software, Consumer Internet, Research, Demand-Side Marketing (DSP), Hardware, Health Diagnostics, Medical, Sensors, Therapeutics, Air Transportation, Pharmaceuticals may find it worthwhile to explore potential connections with Ita Lu, as their portfolio suggests a familiarity and interest in this area.

Understanding Ita Lu’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.